Serum uric acid 570umol/L is considered to be elevated uric acid, which is a more serious condition and requires active uric acid control treatment.
The normal value of serum uric acid is 89-357 μmol/L for adult women and 150-416 μmol/L for adult men, and the diagnosis of hyperuricemia is made when the fasting blood uric acid level exceeds 420 μmol/L on two occasions not on the same day, under normal dietary circumstances.
A serum uric acid level of 570 μmol/L is considered an elevated uric acid level and is considered a more serious condition. The higher the blood uric acid value and the longer it lasts, the greater the risk of causing gouty attacks, uric acid urinary tract stones, and gouty nephropathy. Persistent hyperuricemia can increase the risk of insulin resistance, atherosclerosis, cardiovascular disease, and diabetes.
Serum uric acid 570μmol/L has reached the indication of initiating uric acid-lowering treatment, and oral uric acid-lowering treatment such as febuxostat and benzbromarone should be prescribed.
It is recommended that patients with elevated uric acid consult the rheumatology and immunology department in a timely manner for standardized diagnosis and treatment under the guidance of the doctor and regular follow-up.